Cormorant Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Cormorant Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-100,000	Closed	-$10M	–	86
2017 Q1	$10M	Sell	100,000 -12,867	-11%	-$1.37M	1.45%	25
2016 Q4	$12.1M	Hold	112,867	–	–	1.64%	20
2016 Q3	$14.1M	Hold	112,867	–	–	1.55%	22
2016 Q2	$12M	Buy	112,867 +1,367	+1%	+$159K	1.7%	20
2016 Q1	$12.8M	Hold	111,500	–	–	1.92%	18
2015 Q4	$15.9M	Hold	111,500	–	–	1.9%	16
2015 Q3	$10M	Hold	111,500	–	–	1.6%	22
2015 Q2	$12.8M	Buy	111,500 +35,000	+46%	+$3.68M	1.71%	18
2015 Q1	$7.31M	Sell	76,500 -13,500	-15%	-$1.01M	1.13%	26
2014 Q4	$6.05M	Sell	90,000 -5,000	-5%	-$310K	0.93%	33
2014 Q3	$5.13M	Sell	95,000 -5,000	-5%	-$246K	1.05%	28
2014 Q2	$4.45M	Buy	+100,000	New	+$4.08M	1.18%	35

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Cormorant Asset Management's CBPO Position: Q2 2017 in Review

Cormorant Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 100,000 shares — an estimated $10M sold.

Cormorant Asset Management first reported a position in CBPO in Q2 2014 and held it in 12 quarters. The position peaked at $15.9M in Q4 2015. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

Cormorant Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
Cormorant Asset Management sold 100,000 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $10M.
Cormorant Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 12 quarters.
Cormorant Asset Management's China Biologic Products Holdings, Inc. position peaked at $15.9M in Q4 2015.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Cormorant Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.